TCT 2014
TCT 2014

September 13-17, 2014

Walter E. Washington Convention Center
Washington, DC

  • Washington
    WASHINGTON, DC WELCOMES TCT

    New Structure and New Schedule:
    Live Cases and Late Breakers now begin on Saturday

  • Early Registation
    Early Registation
    Early Registation
    Don't miss the opportunity to present your abstract at TCT 2014 and be published in the Journal of the American College of Cardiology online supplement.
  • Early Registation
    Early Registation

    Register before April 28 to get the lowest rates and best hotels available

    REGISTER TODAY
Cell Therapy

Cell Therapy

 

Learning Objectives

By the end of this course, participants should be able to:

  • Understand the scientific basis for cell-based therapies
  • Describe new data regarding the capacity of specific cell lineages for cardiac repair
  • Be familiar with results of clinical studies and the status of large-scale efficacy trials
  • Appreciate the developmental strategies of next-generation cells, engineered tissue, and their expected first-in-human uses
  • Appreciate the status of cardiovascular stem cell science at the global level, including development of resources, industry activities, strategies for collaboration, and current applicable policies

Target Audience

This conference is designed for clinicians and clinical investigators, interventional cardiologists, noninvasive cardiologists, cardiac surgeons, research associates, basic science investigators (cell and molecular biologists), members of public and private funding organizations, hospital administrators, program directors, legislators, and regulatory agency personnel.

Activity Evaluation

Online evaluation will address content, presentation, possible bias, and future educational needs.

Please note that the Ninth International Conference on Cell Therapy for Cardiovascular Disease is not CME-accredited. Certificates of Attendance will be available on-site in exchange for a completed course evaluation.

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.

Program Sponsorship and Support

This activity is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from commercial supporters.

What People Are Saying About the Cell Therapy Conference…

Congratulations for such terrific meeting and many thanks for the opportunity. Was a great pleasure and honor to participate.
Francisco F. Avilés, MD, PhD
Congratulations for this great meeting and thank you for the opportunity of presenting. It really was a great pleasure to participate.
Jean-Marc, MD
Great meeting!
Stephen Ellis, MD
Thank you for organizing such a great meeting!
Thomas Ichim, MD

Access Cell Therapy Content on TCTMD.com

Login to TCTMD.com

  • Symposium at AATS
    Future of Valve Surgery
    Apr 28, 2014
    The Fairmont Royal York
    Toronto, CA

    CUPC
    Columbia University Primary Care Conference and Expo
    May 9-10, 2014
    The Javits Convention Center
    New York City, NY

    Transradial Symposium 2014
    Advanced Topics in Transradial Angiography and Intervention
    May 10, 2014
    Hilton Chicago, Waldorf Room
    Chicago, IL

    SCAI Symposium
    New Frontiers in Cardiovascular Medicine: The Next Decade
    May 28, 2014
    Las Vegas, NV

    SCAI Symposium
    Issues with DAPT: A Cased-Based Roundtable with the Experts
    May 29, 2014
    Las Vegas, NV

    SCAI Symposium
    Treatment Strategies for the Complex Decompensated Heart Failure Patient: Drugs and Devices - What and When?
    May 31, 2014
    Las Vegas, NV

    TVT
    Transcatheter Valve Therapies (TVT) 2014
    Jun 5-7, 2014
    The Westin Bayshore Hotel
    Vancouver, Canada

    Transradial Symposium 2014
    Transradial Symposium: Strategies for Success
    Jun 14, 2014
    Marina del Rey Marriott
    Marina del Rey, CA

    LAA Closure
    A Technique-Oriented Course
    Jul 17-19, 2014
    Chicago, IL

    BRS
    Bioresorbable Vascular Scaffolds: Transformational Technology for PCI. A Live Case Demonstration Course
    Jul 24-26, 2014
    The Fairmont Copley Plaza
    Boston, MA

    TCT
    Transcatheter Cardiovascular Therapeutics (TCT) 2014
    Sep 13-17, 2014
    Walter E. Washington Convention Center
    Washington, DC

    The VEINS
    Venous Endovascular Interventional Strategies
    Oct 9-11, 2014
    The Swissotel Hotel
    Chicago, IL

  • CARDIOVASCULAR SUMMIT-TCTAP
    Apr 22-25, 2014
    Seoul, South Korea

    SOLACI in Partnership with TCT
    Sociedad Latinoamericana de Cardiología Intervencionista
    Apr 23-25, 2014
    Buenos Aires, Argentina

    TCT @ AATS
    Apr 26-30, 2014
    Toronto, Canada

    Montréal Live in Partnership with TCT
    23rd Montreal Live Symposium
    Jun 12-14, 2014
    Montreal Heart Institute
    Montreal, Quebec, Canada

    TCT Russia
    Jun 16-18, 2014
    Moscow, Russia

    TCT India
    Advanced CardioVascular Solutions (ACVS) India 2014 with TCT
    Aug 1-4, 2014
    Hyderabad, India

    ICI
    Innovations in Cardiovascular Interventional Cardiology
    Dec 14-16, 2014
    Tel-Aviv, Israel